| Mr David Michael Feniger, PT | |
|
631 Broadway, Bayonne, NJ 07002-3846 | |
| (210) 437-0313 | |
| Not Available |
| Full Name | Mr David Michael Feniger |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 631 Broadway, Bayonne, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255382727 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | QA03000 (New Jersey) | Primary |
| Provider Name | Jag-one Physical Therapy Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1518017144 PECOS PAC ID: 2769584325 Enrollment ID: O20070228000306 |
News Archive
A new study in the Journal of the American Medical Association (JAMA) purports to show that screening for MRSA (methicillin-resistant Staphylococus aureus), a simple skin or nasal swab, is not effective in reducing MRSA hospital infections ("Universal Screening for Methicillin-Resistant Staphylococcus aureus at Hospital Admission and Nosocomial Infection in Surgical Patients," JAMA vol. 299, no. 10, March 12, 2008).
The need for long term studies to establish the best means of treating Diabetes, was underlined by Prof John Cleland from the University of Hull at the ESC Congress in Munich. Prof Cleland listed the latest treatment available for patients and voiced his concern about the side-effects and efficacy of available anti-diabetic drugs.
The fight to treat cancer and eradicate tumors will likely benefit from a new set of treatments if early development phases continue to show promise, according to Kalorama Information. The healthcare market research publisher stated that gene therapies that are able to deliver genetic material to a specific cell population or tumor that will result in the destruction of the tumor.
Array BioPharma Inc. today announced the presentation of positive Phase 1 clinical data for its novel kinesin spindle protein (KSP) inhibitor, ARRY-520. The data, which were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, indicate that ARRY-520 was well tolerated and has shown encouraging preliminary results in the treatment of multiple myeloma.
According to a new study, child adversities, which are known to play an important role in mental and physical health, are also associated with poor sleep.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr David Michael Feniger, PT 8 Hawthorn Dr., Westfield, NJ 07090 Ph: (908) 233-0973 | Mr David Michael Feniger, PT 631 Broadway, Bayonne, NJ 07002-3846 Ph: (210) 437-0313 |
News Archive
A new study in the Journal of the American Medical Association (JAMA) purports to show that screening for MRSA (methicillin-resistant Staphylococus aureus), a simple skin or nasal swab, is not effective in reducing MRSA hospital infections ("Universal Screening for Methicillin-Resistant Staphylococcus aureus at Hospital Admission and Nosocomial Infection in Surgical Patients," JAMA vol. 299, no. 10, March 12, 2008).
The need for long term studies to establish the best means of treating Diabetes, was underlined by Prof John Cleland from the University of Hull at the ESC Congress in Munich. Prof Cleland listed the latest treatment available for patients and voiced his concern about the side-effects and efficacy of available anti-diabetic drugs.
The fight to treat cancer and eradicate tumors will likely benefit from a new set of treatments if early development phases continue to show promise, according to Kalorama Information. The healthcare market research publisher stated that gene therapies that are able to deliver genetic material to a specific cell population or tumor that will result in the destruction of the tumor.
Array BioPharma Inc. today announced the presentation of positive Phase 1 clinical data for its novel kinesin spindle protein (KSP) inhibitor, ARRY-520. The data, which were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, indicate that ARRY-520 was well tolerated and has shown encouraging preliminary results in the treatment of multiple myeloma.
According to a new study, child adversities, which are known to play an important role in mental and physical health, are also associated with poor sleep.
› Verified 4 days ago
Revitalyz Wellness Center, Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1222 John F. Kennedy Blvd, Bayonne, NJ 07002 Phone: 201-932-0197 | |
Opt Rehab Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 866 Broadway Ste A, Bayonne, NJ 07002 Phone: 201-600-9488 | |
Magdolin Mishel Samy Saad Shenouda, PT, DPT, PH.D. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 317 Avenue C, Bayonne, NJ 07002 Phone: 201-380-6385 | |
Chitra Kanani, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 665 Broadway, Bayonne, NJ 07002 Phone: 201-875-6691 Fax: 201-455-6691 | |
Roman Kupinski, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 115 W 42nd St, Bayonne, NJ 07002 Phone: 201-243-6662 Fax: 732-855-9755 | |
Drashti Pandya, Physical Therapist Medicare: Medicare Enrolled Practice Location: 864 Broadway, Bayonne, NJ 07002 Phone: 732-593-9295 | |
Sunita Vijaykumar Nair, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 11 W 25th St, Bayonne, NJ 07002 Phone: 201-437-0013 |